Publications

34 résultats Voir en premier : les plus pertinents | les plus récents
    • Statistiques, Drogues
    • 2012
    • Rapport
    • Anglais, Français

    Le rapport 2012 sur l’état du phénomène de la drogue au Grand-Duché de Luxembourg (RELIS) vise à situer le contexte dans lequel s’inscrivent l’usage et le trafic illicites de drogues et les toxicomanies au niveau national en proposant une vue d’ensemble des évolutions historiques et les tendances actuellement observées en la matière.

    • Date de parution:
    • Editeur: Luxembourg Institute of Health
    • Maladies, Santé sexuelle, Statistiques
    • 2012
    • Rapport
    • Anglais

    [Indice européen de performance pour la lutte contre l'hépatite]
    Chaque année, les troubles hépatiques causent 125.000 décès en Europe, où quelques 23 millions de personnes sont atteintes, le plus souvent sans le savoir, d'une forme d'hépatite. Ces personnes constituent par conséquent un facteur de risque élevé eu égard à la propagation de cette infection. Une nouvelle étude vient d'être menée afin de comparer les traitements et les politiques de lutte contre l'hépatite dans 30 pays européens, et ainsi identifier les approches les plus efficaces afin d'élaborer une méthodologie de référence à l'échelle paneuropéenne pour la lutte contre l'hépatite. La France arrive en tête, suivie de la Slovénie et de l'Allemagne. Le Luxembourg se classe 19e, avec 663 points sur 1.000.

    • Date de parution:
    • Editeur: Health Consumer Powerhouse
    • Maladies, Statistiques
    • 2012
    • Rapport
    • Anglais

    [Statistiques européennes de maladies cardiovasculaires 2012]
    This is the fourth edition of European Cardiovascular Disease Statistics. This fourth edition is published jointly by the European Heart Network, the European Society of Cardiology and the British Heart Foundation Health Promotion Research Group, Department of Public Health, University of Oxford. It is part of the European Heart Health Strategy II (EuroHeart II) project and benefits from co-funding from the European Union in the framework of the health programme. CVD remains the main cause of death in Europe with very significant differences in mortality rates between countries.
    The differences are greatest between Northern, Southern and Western European countries and Central and Eastern European Countries. There are also differences between Western and Southern European countries with Southern European countries still having lower death rates from CVD than Western European countries. However, policy makers need to consider the differences and take a close look at risk factor prevalence and trends. Differences between Southern and Western European countries may persist but they are narrowing. This may be good news for Western Europe not necessarily for Southern Europe.
    The data presented in the fourth edition of European Cardiovascular Disease Statistics show that our efforts to reduce mortality from cardiovascular diseases have been successful. Most noticeably, following steep increases in CVD mortality in some Central and Eastern European countries, these countries are now since the mid-2000 experiencing a decrease. However, the cost to the European Union economies of cardiovascular diseases (CVD) is not decreasing.
    A read through the chapters of the European Cardiovascular Disease Statistics confirms that Europe suffers badly from lack of data and, particularly, lack of comparable data. This is true for prevalence and incidence rates, rates of surgical procedures as well as for diets. The European Union has an important task in developing standard methods for collecting information or agreed procedures for calibration of locally appropriate methods and questionnaires, to ensure effective service planning and quality of care for patients across the European Union.

    • Date de parution:
    • Editeur: European Heart Network (EHN)
    • Santé mentale, Travail
    • 2012
    • Rapport
    • Anglais

    [Gestion des risques psychosociaux au travail: une analyse des résultats de l'enquête européenne des entreprises sur les risques nouveaux et émergents (ESENER)]
    In 2009, EU-OSHA carried out the first Europe-wide establishment survey on health and safety at the workplace, the European Survey of Enterprises on New and Emerging Risks (ESENER). Following on from the initial analysis presented in the descriptive overview report in 2010, four secondary analysis projects have been carried out in 2011. This report focuses on management of psychosocial risks at work, exploring how practices vary across Europe depending on, for example, establishment size, location and sector.

    • Date de parution:
    • Editeur: Publications Office of the European Union
    • Santé mentale, Travail
    • 2012
    • Rapport
    • Anglais

    [Facteurs de réussite et obstacles à la gestion des risques psychosociaux: une analyse des résultats de l'enquête européenne des entreprises sur les risques nouveaux et émergents (ESENER)]
    In 2009, EU-OSHA carried out the first Europe-wide establishment survey on health and safety at the workplace, the European Survey of Enterprises on New and Emerging Risks (ESENER). Following on from the initial analysis presented in the descriptive overview report in 2010, four secondary analysis projects have been carried out in 2011. This report focuses on drivers and barriers for psychosocial risks, examining the needs for support that European enterprises should be provided with to manage psychosocial risks effectively.

    • Date de parution:
    • Editeur: Publications Office of the European Union
    • Politique internationale
    • 2012
    • Rapport
    • Anglais

    [Sante 2020: cadre politique et stratégie]
    Health 2020 is the new European health policy framework. It aims to support action across government and society to: “significantly improve the health and well-being of populations, reduce health inequalities, strengthen public health and ensure people-centred health systems that are universal, equitable, sustainable and of high quality”.

    • Date de parution:
    • Editeur: Organisation Mondiale de la Santé (OMS) [World Health Organization (WHO)]
    • Environnement
    • 2012
    • Rapport
    • Anglais

    [Les inégalités en matière d'hygiène de l'environnement en Europe. Rapport d'évaluation]

    The unequal distribution of people’s exposure to – and potentially of disease resulting from – environmental conditions is strongly related to a range of sociodemographic determinants. Interventions to tackle such environmental health inequalities need to be based on an assessment of their magnitude and on the identification of population groups that are most exposed or most vulnerable to environmental risks. But data are scarce.

    To address this gap, and follow up on the commitments made at the Fifth Ministerial Conference on Environment and Health in Parma, Italy in 2010, the WHO Regional Office for Europe has carried out a baseline assessment of the magnitude of environmental health inequality in the European Region based on a core set of 14 inequality indicators.

    The main findings indicate that socioeconomic and demographic inequalities in risk exposure are present in all countries, though they vary from country to country. The report reviews inequalities related to housing, injuries, and the environment, identifies gaps in evidence that still need to be filled, and suggests priority action to be taken at both the subregional and the national level, bearing in mind those national variations.

    • Date de parution:
    • Editeur: Organisation Mondiale de la Santé (OMS) [World Health Organization (WHO)]
    • Santé mentale, Statistiques
    • 2012
    • Rapport
    • Anglais

    [La santé mentale en période de crise économique]
    This report summarises the presentations and discussions at the Workshop on Mental Health in times of Economic crisis, held at the European Parliament in Brussels, on Tuesday, 19 June 2012. The aim of the workshop was to exchange views on the detrimental effects of the economic crisis on the mental health of European citizens.

    • Date de parution:
    • Editeur: Parlement Européen [European Parliament]
    • Drogues, Politique internationale
    • 2012
    • Rapport
    • Anglais

    [Évaluation de la mise en œuvre de la Stratégie antidrogue de l'UE 2005-2012 et plans d'action connexes]

    Publication disponible en version électronique sur le site de l'éditeur RAND

    Illicit drug use continues to be an important public health and safety concern in Europe. Production, trafficking and dealing in illicit drugs constitute important criminal justice challenges in themselves, and are associated with other criminal activities. The 2005-2012 EU Drugs Strategy (as with previous strategies) was developed to complement and add value to national strategies and approaches while respecting the principles of subsidiarity and proportionality set out in the EU Treaties. The main rationale for its development was that while drugs problems vary across Member States, and are experienced at the local and national level, they are "a global issue that needs to be addressed in a transnational context". RAND Europe undertook an independent evaluation of the current Strategy and its Action Plans, addressing four research objectives:

    • To assess barriers and facilitators to the implementation of objectives and priorities at EU and Member State level
    • To assess the relevance and influence of the Strategy with respect to national drugs policy and legislation
    • To assess possible impact on the drugs situation in the EU
    • To identify key aspects and recommendations for future EU Drugs Strategies

    • Date de parution:
    • Editeur: RAND Corporation
    • Politique internationale
    • 2012
    • Rapport
    • Anglais

    [La gouvernance pour la santé au XXIe siècle]

    Cette étude décrit les tentatives des pouvoirs publics ou d'autres acteurs d'orienter les communautés, des pays entiers, voire même des groupes de pays vers la poursuite de la santé comme partie intégrante du bien-être. Elle examine les innovations récentes en matière de gouvernance en vue d'agir sur les déterminants prioritaires de la santé, et les classe en cinq approches stratégiques de gouvernance intelligente pour la santé.

    Governance for health describes the attempts of governments and other actors to steer communities, whole countries or even groups of countries in the pursuit of health as integral to well-being. This study tracks recent governance innovations to address the priority determinants of health and categorizes them into five strategic approaches to smart governance for health. It relates the emergence of joint action by the health sector and non-health sectors, by public and private actors and by citizens, all of whom have an increasing role to play in achieving seminal changes in 21st-century societies.

    This study was commissioned to provide the evidence base for the new European health policy, Health 2020. Calling for a health-in-all-policies, whole-of-government and whole-of-society approach, Health 2020 uses governance as a “lens” through which to view all technical areas of health.

    • Date de parution:
    • Editeur: Organisation Mondiale de la Santé (OMS) [World Health Organization (WHO)]
  • Dernière modification le 12-10-2015